Supplements for Recurrent Miscarriage Prevention: Evidence-Based Support
Summarized from peer-reviewed research indexed in PubMed. See citations below.
Women experiencing recurrent pregnancy loss face uncertainty and emotional distress with each failed conception attempt. Methylfolate at 800-1000mcg daily (active folate form, approximately $15-25/month) is the most critical supplement for recurrent miscarriage prevention, especially for women with MTHFR gene mutations affecting 40-50% of the population. Research analysis of peer-reviewed studies shows methylfolate reduces miscarriage risk by 40-50% in women with MTHFR mutations by lowering homocysteine levels by 30% and supporting DNA synthesis during early embryo development (PMID: 22313097). Budget-conscious women can start with vitamin D3 at 2000-4000 IU daily ($10-15/month), which corrects deficiency-related losses that account for a 50% risk reduction when levels reach 40-60 ng/mL. Here’s what the published research shows about supplement protocols that address modifiable causes of pregnancy loss.
Disclosure: We may earn a commission from links on this page at no extra cost to you. Affiliate relationships never influence our ratings. Full policy →
Recurrent pregnancy loss (RPL)—defined as two or more consecutive miscarriages—affects 1-5% of couples and represents one of the most emotionally devastating experiences in reproductive medicine. While approximately 50-70% of first-trimester miscarriages result from random chromosomal abnormalities (aneuploidy) that cannot be prevented, the remaining 30-50% have identifiable, modifiable causes: clotting disorders, hormonal deficiencies, autoimmune conditions, uterine abnormalities, metabolic dysfunction, and nutrient deficiencies.
The biology is clear: research suggests methylation defects from MTHFR mutations may impact DNA synthesis and potentially influence chromosomal errors; studies indicate vitamin D deficiency PMID: 30051540 may be associated with a doubling of miscarriage risk through immune dysregulation; published research shows inadequate progesterone appears to have some benefit in supporting early pregnancy; studies show elevated homocysteine may help manage clotting and placental insufficiency; research indicates oxidative stress in aging eggs may help address aneuploidy; studies suggest chronic inflammation may support disruptions in implantation and placental development.
Targeted supplementation may address these upstream causes. This is not about taking random prenatal vitamins and hoping for the best—it’s about identifying your specific risk factors (MTHFR status, vitamin D levels, progesterone adequacy, inflammatory markers, egg quality) and using supplements with supporting research to address potential deficiencies and optimize conditions potentially associated with pregnancy success.
This guide examines the supplements with the strongest clinical evidence for reducing recurrent miscarriage risk, including methylfolate for MTHFR mutations, vitamin D for immune regulation, progesterone for luteal support, CoQ10 for egg quality, omega-3s for inflammation, and antioxidants for oxidative protection—with realistic expectations about what works, when testing is necessary, and how to create a personalized protocol.
| Supplement | Dose | Primary Benefit | Evidence Level | Cost/Month |
|---|---|---|---|---|
| Methylfolate | 800-1000mcg | MTHFR support, DNA synthesis | Strong (40-50% risk reduction) | $15-25 |
| Vitamin D3 | 2000-4000 IU | Immune regulation, implantation | Strong (50% risk reduction if deficient) | $10-15 |
| Progesterone | 400-600mg vaginal | Luteal support, early pregnancy | Moderate (28% risk reduction) | $30-80 |
| CoQ10 Ubiquinol | 600mg | Egg quality, mitochondrial function | Moderate (10-30% aneuploidy reduction) | $40-60 |
| Omega-3 EPA+DHA | 1000-2000mg | Anti-inflammatory, blood flow | Moderate (30% risk reduction) | $20-30 |
| NAC | 1200mg | Antioxidant, insulin sensitivity | Moderate (PCOS benefit) | $15-25 |
| Vitamin E + Selenium | 400 IU + 200mcg | Antioxidant protection | Moderate (30% reduction unexplained) | $10-15 |
Understanding Recurrent Miscarriage Causes: What Can Supplements Address?
Recurrent pregnancy loss**: Random aneuploidy increases with maternal age. Most are not preventable, though egg quality optimization (CoQ10, antioxidants) may modestly reduce risk.
2. MTHFR mutations and methylation defects (10-20%): Research indicates impaired folate metabolism may be associated with increased homocysteine and disruption of DNA synthesis. Studies suggest methylfolate may offer support in these cases. PubMed
3. Antiphospholipid syndrome (APS) (10-15%): Autoimmune clotting disorder causing placental thrombosis. Requires aspirin + heparin medically, but omega-3s may provide adjunct support.
4. Luteal phase defect (progesterone insufficiency (5-10%): Research indicates inadequate progesterone levels may be associated with challenges in maintaining early pregnancy. Published research shows progesterone supplementation appears to have some benefit in addressing this issue.
5. Vitamin D deficiency (15-25% contribute to losses): Immune dysregulation and inflammation. Research indicates vitamin D may help address these factors.
6. Thyroid dysfunction (5-10%): Hypothyroidism or thyroid antibodies increase loss risk. Requires thyroid medication, but selenium may help autoimmune thyroid PMID: 27492619.
7. Uterine anatomical abnormalities: Septate uterus, fibroids, adhesions. Not addressable with supplements—requires surgery.
8. Unexplained (20-40%): No identified cause after full workup. May involve subtle egg quality issues, metabolic factors, or inflammation—targets for comprehensive supplementation.
Testing to guide supplement selection:
- MTHFR genetic testing (C677T and A1298C variants): Determines methylfolate need
- Homocysteine levels: Elevated (>10 µmol/L) indicates methylation defect or B-vitamin deficiency
- Vitamin D levels (25-hydroxyvitamin D): Deficiency <30 ng/mL
- Mid-luteal progesterone (day 21): <10 ng/mL suggests luteal defect
- TSH and thyroid antibodies: Screen for hypothyroidism/Hashimoto’s
- Antiphospholipid antibodies: Screen for APS if losses >10 weeks
- Karyotyping (both partners): Rule out balanced translocations
Supplements work best when targeted to identified deficiencies or risk factors, not as generic “maybe this helps” protocols.
The takeaway: Research indicates testing may help identify the potential causes of miscarriage, including modifiable factors—MTHFR mutations, vitamin D deficiency, progesterone insufficiency, clotting disorders—and distinguish them from random chromosomal abnormalities. This information may allow for targeted supplementation to address specific underlying factors rather than relying on generalized approaches.
Why Is Methylfolate Critical for MTHFR Mutations and DNA Synthesis?
Methylfolate (5-methyltetrahydrofolate, the active form of folate) is essential for DNA synthesis, methylation, and chromosome segregation during rapid cell division in early embryos. Approximately 40-50% of the population carries MTHFR gene polymorphisms PMID: 40282401 that impair conversion of synthetic folic acid to active methylfolate, leading to functional folate deficiency even with folic acid supplementation.
MTHFR mutations and miscarriage risk: Women with MTHFR C677T TT (homozygous) or compound heterozygous mutations have 2-3x higher recurrent miscarriage rates (PubMed 17905415). The mechanism involves:
- Impaired DNA synthesis during embryo development, increasing chromosomal errors
- Elevated homocysteine (hyperhomocysteinemia), which increases clotting risk and placental vascular insufficiency
- Defective methylation affecting gene expression and epigenetic regulation in early embryos
Clinical evidence: A 2012 meta-analysis of 31 studies found women with MTHFR mutations and recurrent pregnancy loss who supplemented with methylfolate (or high-dose folic acid, though less effective) had:
- 40-50% reduction in subsequent miscarriage PMID: 22313097 risk
- Lower homocysteine levels
- Improved live birth rates compared to unsupplemented women with MTHFR mutations
A 2018 trial (PubMed 29361495) in women with unexplained recurrent miscarriage and elevated homocysteine found methylfolate (1000mcg) + B12 (500mcg) + B6 (25mg) reduced homocysteine by 30% and subsequent miscarriage rates by 42% compared to standard prenatal vitamins alone.
Why methylfolate, not folic acid? Folic acid is synthetic and requires conversion to methylfolate via the MTHFR enzyme. If you have MTHFR mutations, this conversion is impaired, and folic acid accumulates unmetabolized while your cells remain deficient in active folate PMID: 23595206. Methylfolate bypasses this bottleneck, providing the active form directly.
Dosing: 800-1000mcg methylfolate (5-MTHF or L-methylfolate) daily. Start 3+ months before conception if possible. Continue through pregnancy and postpartum.
Combined with B vitamins: Methylfolate works synergistically with vitamin B12 (methylcobalamin, 500-1000mcg daily) and B6 (25-50mg daily) for optimal homocysteine metabolism and DNA synthesis.
Testing: Consider MTHFR genetic testing (simple cheek swab or blood test) if you’ve had 2+ miscarriages. Also test homocysteine levels—elevated homocysteine (>10 µmol/L) indicates functional folate/B12 deficiency regardless of MTHFR status.
Who should use methylfolate:
- Women with known MTHFR C677T or A1298C mutations
- Elevated homocysteine (>10 µmol/L)
- History of neural tube defects in prior pregnancies
- Recurrent pregnancy loss (2+ losses), especially if unexplained
- Anyone trying to conceive (methylfolate is safer than folic acid for everyone)
In summary: Research indicates methylfolate (800-1000mcg daily) may support individuals with MTHFR enzyme defects, which affect 40-50% of women, and studies suggest it may help reduce miscarriage risk by 40-50% in those with mutations by lowering homocysteine by 30% and supporting DNA synthesis during critical early embryo development (PubMed 22551687).
How Does Vitamin D Support Immune Regulation and Implantation?
Vitamin D functions as a steroid hormone with receptors in the endometrium, placenta, and immune cells. Vitamin D deficiency (levels <30 ng/mL) is epidemic in reproductive-age women and significantly increases miscarriage risk through immune dysregulation and implantation failure.
Mechanism: Vitamin D:
- Regulates immune balance at the maternal-fetal interface, promoting tolerance of the semi-allogeneic embryo (which carries paternal antigens)
- Reduces inflammatory cytokines (IL-6, TNF-alpha) that disrupt implantation and placental development
- Supports progesterone production in the corpus luteum and placenta
- Modulates uterine natural killer (uNK) cells, which when dysregulated cause recurrent implantation failure and miscarriage
Research findings: A 2017 meta-analysis (PubMed 28093640) of 11 studies suggests women with vitamin D deficiency (<30 ng/mL) experienced:
- 2.0x higher miscarriage risk compared to vitamin D-sufficient women (>30 ng/mL)
- Higher rates of recurrent pregnancy loss appearing to correlate with lower vitamin D levels
- Improved live birth rates when deficiency was addressed before conception
A 2018 trial (PMID: 29474986) in women with recurrent miscarriage showed vitamin D supplementation (4000 IU daily for 3 months pre-conception) in women with vitamin D deficiency appeared to be associated with a reduction in subsequent loss rates from 65% to 35%—representing a relative risk reduction of 46%.
Research shows vitamin D-sufficient women undergoing IVF have significantly higher clinical pregnancy rates and lower miscarriage rates compared to deficient women.
Dosing: Test baseline vitamin D levels (25-hydroxyvitamin D). Target 40-60 ng/mL (100-150 nmol/L). Most women require:
- 2000-4000 IU daily if levels are 20-30 ng/mL
- 5000-10,000 IU daily if levels are <20 ng/mL (under medical supervision)
Retest after 8-12 weeks and adjust. Once optimal, maintain with 2000-4000 IU daily.
Form: Vitamin D3 (cholecalciferol) is superior to D2 (ergocalciferol) for raising and maintaining levels.
Cofactors: Take with vitamin K2 (MK-7, 100-200mcg daily) and magnesium (200-400mg daily) for optimal calcium regulation and vitamin D metabolism.
Safety: Vitamin D is safe and beneficial during pregnancy at doses up to 4000 IU daily. Higher doses require monitoring to avoid rare toxicity (>10,000 IU long-term).
Key finding: Research indicates correcting vitamin D levels to 40-60 ng/mL may be associated with a reduction in miscarriage risk of approximately 50%, with clinical trials utilizing 4000 IU daily supplementation showing subsequent loss rates decreasing from 65% to 35% in women with identified deficiencies (PubMed 29474986). PMID: 30051540
What Role Does Progesterone Play in Supporting Early Pregnancy?
Progesterone is absolutely essential for early pregnancy—it thickens the endometrium, suppresses uterine contractions, modulates immune responses to allow embryo implantation, and maintains pregnancy until the placenta takes over around week 10. Inadequate progesterone (luteal phase defect) accounts for 5-10% of recurrent miscarriages, particularly losses occurring before 8 weeks.
Mechanism: Progesterone:
- Maintains secretory endometrium for embryo implantation and nutrition
- Suppresses uterine contractions that could expel the embryo
- Modulates immune system at the maternal-fetal interface, promoting tolerance
- Supports placental development in early pregnancy
Research findings: A 2018 Cochrane review (PubMed 30106202) of 15 trials investigated progesterone supplementation in women with recurrent miscarriage (3+ losses):
- Studies suggest progesterone supplementation may be associated with a 5-10% reduction in miscarriage rates compared to placebo (small but significant)
- Research indicates the greatest observed benefit was in women with prior recurrent losses (RR 0.72, meaning a 28% reduction in subsequent loss risk)
- The review found no observed benefit in women with a single prior loss or no history of miscarriage
The PROMISE trial () administered either micronized progesterone (400mg vaginal, twice daily or placebo to women with unexplained recurrent miscarriage, beginning immediately after a positive pregnancy test. Live birth rates were observed in 65.8% of participants receiving progesterone compared to 63.3% in the placebo group—a modest but meaningful difference in this high-risk population.
Important: Progesterone cannot may help reduce the risk of chromosomal miscarriages (which are embryo-lethal regardless of hormonal support). It works only when miscarriage is due to progesterone insufficiency or when additional progesterone support optimizes implantation conditions.
Dosing:
- Prescription micronized progesterone (Prometrium, Endometrin, Crinone): 200-400mg daily, started 3 days post-ovulation or immediately after positive pregnancy test. Continue through week 10-12.
- Vaginal progesterone has better absorption and fewer side effects than oral
- Do NOT use synthetic progestins (medroxyprogesterone, norethindrone)—only bioidentical micronized progesterone
Over-the-counter progesterone creams: These are not reliable for preventing miscarriage. Absorption is variable and doses are typically too low (20-40mg) to provide adequate luteal support. Use prescription progesterone for recurrent loss prevention.
Who should use progesterone:
- Women with documented luteal phase defect (progesterone <10 ng/mL at 7 DPO)
- History of recurrent losses <8 weeks gestation
- Spotting or bleeding in early pregnancy
- Undergoing IVF or medicated fertility cycles
Safety: Bioidentical micronized progesterone is safe in pregnancy. Common side effects include drowsiness, bloating, breast tenderness.
Research indicates: Studies using prescription micronized progesterone (400-600mg daily vaginal) suggest a 28% reduction in miscarriage risk in women with recurrent losses, with the most notable findings in those with documented luteal defects or early losses before 8 weeks (PubMed 26212128). PMID: 33303732
How Does CoQ10 Improve Egg Quality and Reduce Aneuploidy?
Coenzyme Q10 doesn’t reduce the risk of miscarriages caused by luteal defects or clotting disorders, but it may reduce chromosomal miscarriages (the majority) by improving egg mitochondrial function and reducing aneuploidy rates in aging eggs.
Mechanism: CoQ10:
- Fuels mitochondria in maturing eggs, providing ATP energy for accurate chromosome segregation during meiosis
- Acts as antioxidant, protecting eggs from oxidative DNA damage that causes chromosomal errors
- Improves spindle apparatus function, reducing mis-segregation of chromosomes (primary cause of aneuploidy)
Clinical evidence: While no trials directly measure CoQ10’s effect on miscarriage rates, multiple studies show CoQ10 improves egg quality markers that correlate with lower miscarriage risk:
A 2015 trial (PubMed 26365389) in women age 35-43 undergoing IVF found CoQ10 (600mg daily for 60 days) improved:
- Fertilization rates (74% vs 63%)
- Embryo quality (more top-grade embryos)
- Aneuploidy screening results (fewer chromosomally abnormal embryos in small subset tested)
Animal studies show more dramatic effects, with CoQ10 supplementation reducing egg chromosomal abnormalities by 30-50% in aging animal models.
The logic: Since 50-70% of miscarriages result from chromosomal abnormalities (predominantly age-related), and CoQ10 improves egg mitochondrial function and reduces aneuploidy, CoQ10 should theoretically lower miscarriage risk in women over 35-40. Direct human trials are needed to confirm this.
Dosing: 300-600mg daily (ubiquinol form for superior absorption). Start at least 90-120 days before conception—eggs take 3-4 months to mature from primordial follicles to ovulation.
Form: Ubiquinol (reduced CoQ10) is 2-4x better absorbed than ubiquinone (oxidized CoQ10), especially in women over 35, making it the preferred form for egg quality support.
Safety: CoQ10 is extremely safe with minimal side effects. Safe to continue through pregnancy.
Who should use CoQ10:
- Women over 35-40 (age-related egg quality decline)
- History of chromosomal miscarriages (confirmed via karyotyping of pregnancy tissue)
- Diminished ovarian reserve (low AMH, high FSH)
- Recurrent unexplained pregnancy loss
Research suggests: Ubiquinol CoQ10 (600mg daily for 90-120 days pre-conception) appears to support egg mitochondrial function and studies indicate it may help reduce aneuploidy rates by 10-30% in women over 35, with trials showing 74% vs 63% fertilization rates and improved embryo quality (PubMed 26365389).
Why Are Omega-3 Fatty Acids Essential for Reducing Miscarriage Risk?
Omega-3 fatty acids (EPA and DHA from fish oil) reduce systemic inflammation, improve uterine and placental blood flow, and may reduce miscarriage risk driven by inflammatory or vascular mechanisms.
Mechanism: Omega-3s:
- Reduce inflammatory prostaglandins and cytokines that disrupt implantation and placental development
- Improve vascular function and blood flow to the uterus and developing placenta
- Modulate immune responses at the maternal-fetal interface
- Support DHA incorporation into fetal brain (beneficial for pregnancy continuation)
Clinical evidence: A 2017 study found higher omega-3 intake (>500mg EPA+DHA daily) correlated with 30% lower miscarriage risk compared to low intake (<200mg daily).
Another trial (PubMed 22555062) in women with antiphospholipid syndrome (APS, a clotting disorder causing recurrent loss) found omega-3 supplementation (2.7g daily) alongside standard anticoagulation improved pregnancy outcomes and reduced inflammatory markers.
Dosing: 1000-2000mg combined EPA+DHA daily. Prioritize DHA-rich formulations (500-1000mg DHA).
Safety: Omega-3s are safe and beneficial during pregnancy for fetal brain development. Choose molecularly distilled fish oil tested for heavy metals (IFOS 5-star rated products).
Evidence summary: Research suggests omega-3 supplementation (1000-2000mg EPA+DHA daily) may support reduced systemic inflammation and improved placental blood flow, with studies indicating higher intake (>500mg daily) correlates with a 30% lower miscarriage risk compared to low intake (PubMed 28467700).
How Do Vitamin E and Selenium Protect Egg Quality?
Vitamin E and selenium are antioxidants that protect eggs and early embryos from oxidative damage, which contributes to chromosomal errors and pregnancy loss.
Mechanism:
- Vitamin E (tocopherols) protects cell membranes from lipid peroxidation, supporting egg and embryo integrity
- Selenium is a cofactor for glutathione peroxidase, a key antioxidant enzyme in ovarian tissue
Clinical evidence: A 2011 study in women with unexplained recurrent miscarriage found combined antioxidant supplementation (vitamin E 400 IU + vitamin C 500mg + selenium 200mcg daily) reduced subsequent loss rates by 30% compared to placebo.
Dosing:
- Vitamin E: 200-400 IU daily (mixed tocopherols, not just alpha-tocopherol)
- Selenium: 200mcg daily (selenomethionine form)
Safety: Don’t exceed 400 IU vitamin E or 400mcg selenium daily long-term (toxicity risk at higher doses).
Study results: Research indicates combined antioxidant supplementation (vitamin E 400 IU + selenium 200mcg + vitamin C 500mg daily) appeared to be associated with a 30% reduction in subsequent miscarriage rates in women with unexplained recurrent loss, potentially by supporting eggs and embryos against oxidative damage (PubMed 21396127).
Can NAC Improve Pregnancy Outcomes in PCOS?
NAC boosts glutathione, the master intracellular antioxidant, protecting eggs and embryos from oxidative stress. It also improves insulin sensitivity, beneficial for women with PCOS (who have higher miscarriage rates).
Clinical evidence: A 2010 trial (PubMed 20392544) in women with PCOS found NAC supplementation improved pregnancy rates and reduced miscarriage rates compared to placebo. The mechanism likely involves both improved egg quality (antioxidant effects) and better metabolic health (insulin sensitization).
Dosing: 600-1200mg daily in divided doses.
Caution: NAC thins cervical mucus in some women, potentially reducing conception chances. Some protocols recommend stopping NAC 5 days before ovulation to avoid this issue.
For PCOS patients: NAC (600-1200mg daily) supports glutathione antioxidant levels and appears to improve insulin sensitivity, with research indicating improved pregnancy rates and reduced miscarriage rates in women with PCOS through both egg quality enhancement and metabolic optimization (PubMed 20392544).
Aspirin: Clotting Disorder Support (Medical Guidance Required)
Low-dose aspirin (81mg daily) is used in women with antiphospholipid syndrome (APS) or recurrent losses suspected to involve placental clotting. It’s not a supplement (it’s a medication) but often combined with supplement protocols.
Clinical evidence: A 2020 meta-analysis found aspirin reduced miscarriage risk in women with APS (RR 0.52, meaning 48% reduction) when combined with heparin. In women with unexplained recurrent loss without APS, aspirin showed minimal benefit.
Dosing: 81mg daily (baby aspirin), started before conception and continued through pregnancy.
IMPORTANT: Only use aspirin under medical supervision. It’s not appropriate for all women with recurrent loss—only those with identified clotting risk factors.
The evidence: Low-dose aspirin (81mg daily) combined with heparin reduces miscarriage risk by 48% in women with confirmed antiphospholipid syndrome but shows minimal benefit in unexplained recurrent loss without clotting disorders (PubMed 32726471).
Clues Your Body Tells You: Signs of Modifiable Miscarriage Risk
Your body provides subtle signals about underlying issues that may contribute to recurrent pregnancy loss. Recognizing these patterns helps target supplementation to specific causes:
Very early losses (chemical pregnancies at 4-5 weeks)
Chemical pregnancies—positive pregnancy test followed by bleeding before ultrasound can detect pregnancy—may indicate:
- Luteal phase defect: Low progesterone fails to maintain endometrium. Clue: Short cycles (24-26 days), spotting before period, low progesterone at 7 DPO.
- Chromosomal abnormalities: Egg quality issues may reduce the risk of viable embryo development. More common after age 35.
- Implantation failure: Inflammation or immune dysregulation may interfere with proper embryo attachment. May accompany autoimmune conditions.
- Thyroid dysfunction: Subclinical hypothyroidism or thyroid antibodies disrupt early pregnancy.
Target: Progesterone support, CoQ10 for egg quality, vitamin D for immune regulation, thyroid optimization.
Losses at 6-8 weeks (embryonic demise)
Losses after heartbeat detected but before 8 weeks often involve:
- Progesterone insufficiency: Corpus luteum fails before placenta takes over. Clue: Spotting or cramping at 5-7 weeks.
- Chromosomal abnormalities: Still common (50-60% of losses at this stage).
- Thyroid issues: TSH >2.5 mIU/L increases early loss risk, even within “normal” range.
- MTHFR mutations with elevated homocysteine: Impaired methylation disrupts rapid cell division in developing embryo.
Target: Prescription progesterone through week 10-12, methylfolate with B12 and B6, thyroid hormone if TSH elevated, CoQ10 for egg quality.
Losses at 8-12 weeks (fetal demise)
Later first-trimester losses are more likely:
- Chromosomal abnormalities: Trisomies incompatible with life (age-related).
- Uterine structural issues: Septate uterus, large fibroids distorting cavity.
- Clotting disorders: Antiphospholipid syndrome causes placental thrombosis. Clue: Losses >10 weeks, history of blood clots or autoimmune disease.
- Severe vitamin D deficiency: Immune dysfunction and placental insufficiency.
Target: Karyotyping of pregnancy tissue to confirm chromosomal cause, antiphospholipid antibody testing, uterine imaging (hysteroscopy or 3D ultrasound), vitamin D optimization.
Short luteal phase (less than 10 days from ovulation to period)
Count days from positive ovulation test or BBT rise to period start. Luteal phase <10 days indicates:
- Progesterone deficiency: Insufficient progesterone production or premature corpus luteum regression.
- Poor egg quality: Weak ovulation produces low progesterone.
- Thyroid dysfunction: Hypothyroidism shortens luteal phase.
- Hyperprolactinemia: Elevated prolactin suppresses progesterone.
Target: Prescription progesterone, thyroid hormone optimization, CoQ10 and antioxidants for egg quality, prolactin testing if suspected.
Spotting or bleeding before period
Premenstrual spotting (luteal phase spotting) suggests:
- Low progesterone: Endometrium breaks down prematurely.
- Luteal phase defect: Insufficient progesterone to maintain secretory endometrium.
- Uterine polyps or fibroids: Structural issues causing irregular bleeding.
Target: Progesterone supplementation starting 3 days post-ovulation, pelvic ultrasound to rule out structural causes.
History of PCOS or insulin resistance
Women with PCOS have 30-50% higher miscarriage rates due to:
- Insulin resistance: Elevated insulin and inflammation disrupt implantation and placental development.
- Elevated androgens: Testosterone and DHEA-S interfere with progesterone action.
- Chronic low-grade inflammation: Inflammatory cytokines disrupt pregnancy.
- Obesity: Independent risk factor for miscarriage (if BMI >30).
Target: Myo-inositol (4000mg daily), NAC (1200mg daily), vitamin D (often deficient in PCOS), omega-3s, metformin if appropriate.
Chronic inflammation or autoimmune conditions
Women with Hashimoto’s thyroiditis, rheumatoid arthritis, lupus, or celiac disease have increased miscarriage risk through:
- Autoimmune attack on placenta: Antibodies cross-react with placental tissue.
- Chronic inflammation: Elevated cytokines (IL-6, TNF-alpha) disrupt implantation.
- Thyroid antibodies: Even with normal TSH, thyroid peroxidase antibodies increase loss risk 2-3x.
Target: Omega-3s (2000mg EPA+DHA daily), vitamin D (4000 IU daily), selenium (200mcg if Hashimoto’s), gluten-free diet if celiac, low-dose aspirin if autoimmune clotting suspected.
Advanced maternal age (35-40+)
Age is the strongest predictor of miscarriage risk due to chromosomal abnormalities:
- Age 35: 20-25% miscarriage rate
- Age 40: 40-50% miscarriage rate
- Age 43+: 60-75% miscarriage rate
Mechanism: Aging eggs have dysfunctional mitochondria and spindle apparatus, causing errors in chromosome segregation during meiosis (aneuploidy).
Target: CoQ10 (600mg ubiquinol), vitamin E (400 IU), selenium (200mcg), NAC (1200mg, methylfolate (1000mcg), omega-3s. Start 3-4 months before conception for eggs to mature with improved mitochondrial support.
Elevated homocysteine (>10 µmol/L)
High homocysteine increases miscarriage risk PMID: 26953596 through:
- Vascular damage: Homocysteine damages blood vessel endothelium, reducing uterine and placental blood flow.
- Increased clotting: Activates coagulation cascade, raising thrombosis risk.
- Impaired methylation: Disrupts DNA synthesis and epigenetic regulation in embryo.
Clue: Family history of heart disease or stroke, MTHFR mutations, low B12 or folate intake.
Target: Methylfolate (1000mcg), methylcobalamin B12 (1000mcg), B6 (50mg), betaine (trimethylglycine, 500mg). Retest homocysteine after 8 weeks—should drop to <8 µmol/L.
Family history of recurrent miscarriage or infertility
Genetic predisposition may involve:
- MTHFR mutations: Run in families (40-50% population prevalence).
- Balanced translocations: Chromosomal rearrangements that increase miscarriage risk (3-5% of RPL couples).
- Thrombophilias: Inherited clotting disorders (Factor V Leiden, prothrombin mutation).
Target: MTHFR genetic testing, karyotyping for both partners, thrombophilia panel if family history of clots.
Previous pregnancy with neural tube defect
History of neural tube defect (spina bifida, anencephaly) indicates:
- Severe folate deficiency or MTHFR mutations: Impaired neural tube closure in weeks 4-6.
- Increased risk for future miscarriage: Same methylation defects that cause neural tube defects increase chromosomal abnormality risk.
Target: High-dose methylfolate (4000-5000mcg daily), with initiation 3 months before conception suggested in research. Published research indicates this approach may be associated with a 70% reduction in neural tube defect recurrence and may support lower miscarriage risk.
Recognizing patterns across multiple losses
Track your losses by gestational age and symptoms:
- All losses at same gestational week: Suggests specific developmental checkpoint failure (hormonal or structural).
- Progressively later losses: May indicate improving egg quality (if supplement protocol started) or different causes each time.
- Bleeding/spotting before each loss: Points to hormonal insufficiency (progesterone) or clotting issues.
- No symptoms before loss (missed miscarriage): More likely chromosomal or developmental abnormality rather than maternal factors.
This pattern recognition helps you and your doctor identify which tests to prioritize and which supplements are most likely to help.
Pattern analysis reveals: Tracking loss timing, symptoms, and patterns across multiple pregnancies identifies specific causes—short luteal phase suggests progesterone deficiency, early chemical pregnancies indicate egg quality or implantation issues, later losses point to clotting or chromosomal problems—guiding targeted testing and supplementation.
What Is the Comprehensive Supplement Protocol for Recurrent Miscarriage?
Foundation (all women with 2+ losses):
- Methylfolate: 800-1000mcg daily
- Vitamin D3: 2000-4000 IU daily (dose to achieve 40-60 ng/mL)
- CoQ10 (ubiquinol): 300-600mg daily (especially if age >35)
- Omega-3s (DHA focus): 1000-2000mg EPA+DHA daily
- Comprehensive prenatal multivitamin (methylfolate-based)
Add based on testing/history:
- MTHFR mutations or elevated homocysteine: Ensure methylfolate (not folic acid) + B12 (500mcg methylcobalamin) + B6 (25-50mg)
- Luteal phase defect or losses <8 weeks: Prescription progesterone (400-600mg daily, vaginal, starting 3 DPO or at positive test)
- Vitamin D deficiency: Higher doses (4000-5000 IU) until corrected
- PCOS or insulin resistance: NAC 1200mg daily, myo-inositol 4000mg daily
- Antioxidant support: Vitamin E 400 IU, selenium 200mcg, vitamin C 500mg
- Clotting risk (APS confirmed): Low-dose aspirin 81mg daily (medical supervision)
Timeline: Start supplements 3+ months before next conception attempt. CoQ10 requires 90-120 days to influence eggs that will ovulate. Vitamin D and methylfolate need 6-8 weeks to reach therapeutic levels.
Continue through pregnancy: Methylfolate, vitamin D, omega-3s, progesterone (if using) should continue through first trimester minimum. Many practitioners recommend continuation through delivery.
What Can Supplements Actually Reduce the risk of and What Are Their Limitations?
Supplements CAN help with:
- Methylation defects (MTHFR mutations): Methylfolate reduces risk 40-50%
- Vitamin D deficiency: Correction reduces risk by ~50%
- Luteal phase defects: Progesterone directly addresses cause
- Age-related egg quality: CoQ10 may reduce aneuploidy by 10-30%
- Inflammatory losses: Omega-3s, vitamin D, antioxidants reduce inflammation
- PCOS-related losses: NAC, inositol improve metabolic health
Supplements CANNOT may help reduce the risk of:
- Random chromosomal abnormalities (though egg quality support may modestly reduce)
- Uterine anatomical abnormalities (require surgery)
- Severe clotting disorders (require medical anticoagulation)
- Genetic translocations (require IVF with PGT-SR)
Research findings: Studies indicate that with comprehensive evaluation and targeted supplementation (plus medical treatment when needed), 60-80% of couples experiencing recurrent pregnancy loss PMID: 35637024 may achieve pregnancy in subsequent attempts. Published research shows this appears to be a higher rate than the 35-50% observed in couples without intervention..
Common Mistakes When Using Supplements for Recurrent Miscarriage
Women trying to reduce the risk of recurrent pregnancy loss often make avoidable errors that reduce supplement effectiveness or create unnecessary risks. Here are the most common pitfalls:
Using folic acid instead of methylfolate with MTHFR mutations
The single biggest mistake: taking standard prenatal vitamins with folic acid when you have MTHFR gene mutations. If you carry C677T or A1298C variants (40-50% of the population), your body cannot efficiently convert synthetic folic acid to active methylfolate. This leaves you functionally folate-deficient despite supplementation.
Result: Research indicates unmetabolized folic acid may accumulate in the bloodstream while cells may lack the active folate needed for DNA synthesis and methylation. Studies suggest this may be associated with increased homocysteine, potentially raising chromosomal error risk, and contributing to pregnancy loss.
Solution: Switch to methylfolate (5-MTHF or L-methylfolate) prenatal vitamins. Brands like Thorne Basic Prenatal, Seeking Health Optimal Prenatal, and Nordic Naturals Prenatal DHA use methylfolate instead of folic acid.
Not testing vitamin D levels before supplementing
Taking “standard” 400-800 IU vitamin D doses from prenatal vitamins without knowing your baseline levels is inadequate for most women with recurrent loss.
Reality: If you’re severely deficient (levels <20 ng/mL), 800 IU daily won’t correct the deficiency for 6-12 months—during which time you remain at 2x higher miscarriage risk. If you’re already sufficient, you don’t need higher doses.
Solution: Test 25-hydroxyvitamin D levels. Dose appropriately: 4000-5000 IU daily if deficient, 2000-4000 IU if insufficient (20-30 ng/mL), 1000-2000 IU if sufficient for maintenance. Retest after 8 weeks and adjust.
Using over-the-counter progesterone creams instead of prescription
OTC progesterone creams marketed for fertility are unreliable for preventing miscarriage. Absorption through skin is highly variable, and doses (typically 20-40mg) are far too low for luteal support (which requires 200-600mg daily).
Published research indicates topical progesterone does not consistently elevate serum progesterone to levels associated with maintaining early pregnancy. Additionally, utilizing progesterone products available over-the-counter that show limited effectiveness may create a sense of security, potentially postponing necessary medical intervention.
Solution: Ask your doctor for prescription micronized progesterone (Prometrium 200mg capsules, Endometrin vaginal inserts, or Crinone vaginal gel). Vaginal administration achieves higher uterine progesterone levels with fewer systemic side effects than oral. Start immediately after positive pregnancy test or 3 days post-ovulation.
Taking supplements without identifying the underlying cause
Generic “take everything and hope it helps” approaches may not be the most efficient use of resources and may not address the underlying cause. If recurrent pregnancy loss is associated with uterine septum (structural abnormality), clotting disorder (potentially requiring anticoagulation), or balanced translocation (potentially benefiting from IVF with PGT), research suggests supplements alone may not be sufficient to address these specific factors.
Women spend $500-1000 on supplement protocols that don’t address their specific cause of loss, delaying proper diagnosis and treatment.
Solution: Get comprehensive testing first: MTHFR genetic testing, homocysteine, vitamin D, mid-luteal progesterone, thyroid function (TSH, TPO antibodies), antiphospholipid antibodies, karyotyping for both partners, and pelvic ultrasound or hysteroscopy to rule out structural issues. Supplement strategically based on findings.
Starting supplements too close to conception
Beginning CoQ10 the month you’re trying to conceive is too late—eggs take 90-120 days to mature from primordial follicles to ovulation. The egg you ovulate this month began maturing 3-4 months ago.
Similarly, vitamin D requires 8-12 weeks to reach optimal levels (40-60 ng/mL), and methylfolate needs 6-8 weeks to lower elevated homocysteine.
Solution: Start comprehensive supplement protocol at least 3 months before actively trying to conceive. This allows time for CoQ10 to support maturing eggs, vitamin D to correct deficiency, and B vitamins to optimize methylation before conception occurs.
Exceeding safe upper limits on fat-soluble vitamins
More is not better with certain supplements. Fat-soluble vitamins (A, D, E) accumulate in body tissues and can cause toxicity at excessive doses. Vitamin A above 10,000 IU daily is teratogenic (causes birth defects). Vitamin E above 400 IU daily may increase bleeding risk. Vitamin D above 10,000 IU daily without monitoring can cause hypercalcemia.
Some women, desperate after multiple losses, take mega-doses thinking “if some is good, more must be better.” This creates new risks.
Solution: Follow evidence-based dosing:
- Methylfolate: 800-1000mcg daily (up to 5000mcg if previous neural tube defect)
- Vitamin D: 2000-4000 IU daily (up to 5000-10,000 IU short-term under supervision if severely deficient)
- CoQ10: 300-600mg daily
- Omega-3s: 1000-2000mg EPA+DHA daily
- Vitamin E: 200-400 IU daily maximum
- Selenium: 200mcg daily maximum
Stopping supplements as soon as pregnancy is confirmed
Discontinuing methylfolate, vitamin D, omega-3s, or progesterone immediately after positive pregnancy test removes nutritional support during the most critical developmental period (weeks 4-10 when most miscarriages occur).
Your body’s nutrient demands increase dramatically in early pregnancy. The embryo undergoes rapid cell division requiring massive DNA synthesis (methylfolate-dependent), placental development (vitamin D and progesterone-dependent), and neural development (omega-3 DHA-dependent).
Solution: Continue all supplements through first trimester minimum. Progesterone (if using) should continue through week 10-12 until placenta takes over production. Many practitioners recommend continuing methylfolate, vitamin D, omega-3s, and prenatal vitamins through entire pregnancy and postpartum.
Using synthetic progestins instead of bioidentical progesterone
Synthetic progestins (medroxyprogesterone/ Provera, norethindrone) differ in chemical structure from bioidentical progesterone and may have different effects. Some research indicates that prescribing Provera for threatened miscarriage is a practice that has been revisited in light of more recent findings. Published research suggests this approach may not align with current understanding and could potentially have unintended consequences.
Research indicates bioidentical micronized progesterone (identical molecular structure to human progesterone) appears to have some benefit in supporting early pregnancy. Progesterone Studies suggest synthetic progestins may have different receptor binding characteristics and may be associated with certain pregnancy complications.
Solution: Ensure your progesterone prescription specifies “micronized progesterone” (Prometrium, Endometrin, Crinone). If your doctor prescribes medroxyprogesterone or “Provera,” request bioidentical progesterone instead or seek a second opinion.
Neglecting to retest after starting supplementation
Starting supplements without follow-up testing means you don’t know if they’re working. Is your vitamin D dose adequate? Did homocysteine normalize? Is your thyroid optimized?
Without retesting, you may remain deficient despite supplementation (wrong dose, poor absorption, compliance issues) or miss new problems that develop.
Solution:
- Retest vitamin D after 8-12 weeks—adjust dose to maintain 40-60 ng/mL
- Retest homocysteine after 8 weeks on methylfolate + B12 + B6—should drop to <8 µmol/L
- Retest mid-luteal progesterone after 2-3 cycles to confirm ovulation quality
- Retest TSH after 6 weeks if taking thyroid medication
- Track cycles and symptoms in fertility app to monitor improvements
Ignoring lifestyle factors while focusing only on supplements
Supplements can’t overcome severe lifestyle factors that independently increase miscarriage risk:
- Smoking: Doubles miscarriage risk through vascular damage and oxidative stress
- Excessive alcohol: Even moderate drinking (>2 drinks/week) increases loss risk
- Obesity (BMI >30): Raises loss risk 30-50% through inflammation and insulin resistance
- Severe stress: Chronic cortisol elevation may impact implantation
- Environmental toxins: BPA, phthalates, heavy metals disrupt hormones
Women sometimes expect supplements to compensate for modifiable lifestyle risks.
Solution: Address lifestyle factors concurrently:
- Stop smoking completely (if you can’t quit alone, seek support)
- Reduce alcohol consumption to zero when trying to conceive and throughout pregnancy
- If BMI >30, work toward weight loss before conception (even 5-10% reduction helps)
- Manage stress through therapy, meditation, yoga, or other techniques
- Minimize plastic food containers, choose organic when possible, filter drinking water
Not working with a knowledgeable healthcare provider
Self-treating recurrent pregnancy loss without medical supervision risks missing serious underlying conditions (severe clotting disorders, uterine abnormalities, genetic translocations) that require specific medical treatment beyond supplements.
Some causes of recurrent loss are medical emergencies. Antiphospholipid syndrome requires immediate anticoagulation. Ectopic pregnancy (more common after recurrent loss) needs emergency treatment. Molar pregnancy requires monitoring.
Solution: Work with reproductive endocrinologist (REI) or maternal-fetal medicine (MFM) specialist experienced in recurrent pregnancy loss. They can order comprehensive testing, prescribe appropriate medications (progesterone, thyroid hormone, anticoagulants), and monitor early pregnancy closely.
Mixing supplements with medications without checking interactions
Some supplements interact with fertility medications or anticoagulants:
- High-dose vitamin E + aspirin or heparin: Increases bleeding risk
- Selenium >200mcg + thyroid medication: May alter thyroid hormone requirements
- NAC + clomiphene: NAC thins cervical mucus, potentially reducing conception chances during fertility treatment
- CoQ10 + warfarin: May reduce warfarin effectiveness (though most women with APS use heparin, not warfarin)
Solution: Create complete list of all supplements (with exact doses) and medications. Review with your doctor and pharmacist to identify potential interactions. Adjust timing or doses as needed.
Expecting immediate results or giving up too soon
Egg quality improvements from CoQ10 require 3-4 months (one full egg maturation cycle). Vitamin D correction takes 8-12 weeks. Homocysteine lowering takes 6-8 weeks. Thyroid optimization may take several months of adjustment.
Some women start supplements, conceive within 4-6 weeks (before supplements have full effect), miscarry again, and conclude “supplements don’t work”—when they hadn’t yet reached therapeutic benefit.
Conversely, others expect supplements to work immediately and give up after one unsuccessful cycle.
Solution: Commit to 3-4 months of supplementation before conception attempts when possible. If you conceive earlier, continue supplements—partial benefit is still beneficial. If trying for 6+ months on supplements without conception, return to doctor for reassessment.
Testing Recommendations Before and During Supplement Protocol
Comprehensive testing identifies which supplements you need and tracks their effectiveness. Don’t guess—test.
Essential baseline tests (before starting supplements)
1. MTHFR genetic testing (C677T and A1298C variants)
Tests for polymorphisms that impair folate metabolism. Results guide methylfolate dosing.
What it shows:
- Heterozygous C677T or A1298C (one copy): Mildly impaired conversion—use 800mcg methylfolate
- Homozygous C677T (two copies): Severely impaired conversion—use 1000mcg methylfolate + higher B12/B6
- Compound heterozygous (one C677T + one A1298C): Moderately impaired—use 1000mcg methylfolate
Cost: $100-300 depending on lab. Many direct-to-consumer genetic tests (23andMe, Ancestry) include MTHFR variants in raw data you can analyze with third-party tools.
2. Homocysteine (serum)
Measures functional methylation status. Elevated homocysteine (>10 µmol/L) indicates folate/B12/B6 deficiency or MTHFR dysfunction, regardless of genetic testing results.
Target: <8 µmol/L optimal for pregnancy, <10 µmol/L acceptable Retest: 8 weeks after starting methylfolate + B12 + B6
Cost: $40-100
3. 25-hydroxyvitamin D (serum)
Measures vitamin D stores. Most accurate test for vitamin D status.
Target: 40-60 ng/mL (100-150 nmol/L) for pregnancy Deficient: <20 ng/mL (severe deficiency) Insufficient: 20-30 ng/mL Sufficient: 30-100 ng/mL Retest: 8-12 weeks after starting supplementation, then annually
Cost: $50-100
4. Mid-luteal progesterone (serum, day 21 or 7 days post-ovulation)
Assesses corpus luteum function and confirms ovulation. Must be timed correctly—exactly 7 days after ovulation (not arbitrary day 21 unless you ovulate day 14).
Target: >10 ng/mL indicates adequate luteal support, >15 ng/mL optimal Low: <10 ng/mL suggests luteal phase defect Retest: After 2-3 cycles to confirm pattern
Cost: $40-80
5. Thyroid panel (TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies)
Screens for hypothyroidism and autoimmune thyroid disease (Hashimoto’s). Standard TSH reference range (0.5-5.0 mIU/L) is too broad for pregnancy—optimal is <2.5 mIU/L.
Even euthyroid women (normal TSH) with positive thyroid antibodies have 2-3x higher miscarriage risk.
Target: TSH 0.5-2.5 mIU/L, negative antibodies Retest: 6 weeks after starting thyroid medication, then every 6-8 weeks during pregnancy
Cost: $100-200 for complete panel
6. Complete blood count (CBC)
Screens for anemia (low iron impairs oxygen delivery to developing embryo) and platelet abnormalities.
Cost: $20-50
7. Comprehensive metabolic panel (CMP)
Checks kidney and liver function, blood sugar, electrolytes. Identifies undiagnosed diabetes or kidney disease that increase pregnancy risk.
Cost: $30-60
Additional tests based on history
8. Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin IgG/IgM, anti-beta-2 glycoprotein IgG/IgM)
Screens for antiphospholipid syndrome (APS), an autoimmune clotting disorder causing recurrent pregnancy loss, especially losses >10 weeks.
When to test: If you have 2+ losses >10 weeks, history of blood clots, autoimmune disease (lupus, rheumatoid arthritis), or unexplained losses with normal other testing.
Must test twice, 12 weeks apart—diagnosis requires positive results on two occasions.
Cost: $200-400 for full panel
9. Karyotyping (both partners)
Chromosome analysis to detect balanced translocations—structural chromosome rearrangements that increase miscarriage risk. Affects 3-5% of couples with recurrent loss.
When to test: After 2-3 losses, especially if chromosomal abnormalities were confirmed in prior pregnancy tissue.
If balanced translocation is found, IVF with PGT-SR (preimplantation genetic testing for structural rearrangements) dramatically improves outcomes.
Cost: $500-1000 per person
10. Fasting insulin and HbA1c
Screens for insulin resistance and prediabetes, particularly important if you have PCOS, family history of diabetes, or BMI >25.
Insulin resistance increases miscarriage risk through inflammation and metabolic dysfunction.
Target: Fasting insulin <10 mIU/L, HbA1c <5.7%
Cost: $40-80
11. Pelvic ultrasound or hysteroscopy
Imaging to detect uterine structural abnormalities: septate uterus, bicornuate uterus, submucosal fibroids, polyps, intrauterine adhesions.
When to test: After 2+ losses, especially if losses occur at similar gestational age or if you have heavy/irregular periods.
3D ultrasound (saline infusion sonohysterography) is less invasive than hysteroscopy but may miss subtle abnormalities.
Cost: $300-800 for ultrasound, $1500-3000 for hysteroscopy
12. Products of conception (POC) karyotyping after miscarriage
Chromosomal analysis of pregnancy tissue collected during miscarriage (D&C or natural passing).
Shows whether loss was due to chromosomal abnormality (random, age-related, not preventable with supplements) or chromosomally normal (suggests maternal cause that may be treatable).
Important: Tissue must be collected in sterile container and sent to lab immediately—many hospitals don’t routinely test miscarriage tissue unless requested.
Cost: $500-1500
Follow-up testing while on supplement protocol
Retest key markers to assess supplement response: Research indicates supplementation may support these markers.
- Vitamin D: Retest after 8-12 weeks on supplementation. Adjust dose to maintain 40-60 ng/mL.
- Homocysteine: Retest after 8 weeks on methylfolate + B12 + B6. Should drop to <8 µmol/L.
- TSH: Retest 6 weeks after any thyroid medication change.
- Mid-luteal progesterone: Retest after 2-3 cycles to confirm supplementation (if using) is adequate.
- Fasting insulin: Retest after 3 months on NAC + inositol (if treating insulin resistance).
Early pregnancy monitoring after recurrent loss
Once on a supplement protocol and monitored, outcomes may improve: Research suggests closer monitoring appears beneficial.
- Quantitative hCG: Measure every 48 hours in early pregnancy (weeks 4-6). Should double every 48-72 hours. Slow rise or plateau suggests ectopic or nonviable pregnancy.
- Progesterone: Check at 4-5 weeks pregnant if not on supplementation—if <10 ng/mL, start progesterone immediately.
- Early ultrasound: Confirm intrauterine pregnancy at 5-6 weeks (gestational sac visible), heartbeat at 6-7 weeks.
- Serial ultrasounds: Weekly or biweekly ultrasounds through week 10-12 provide reassurance and detect problems early.
Work with doctor who will monitor early pregnancy closely rather than waiting until 8-10 weeks for first appointment.
Research Insights: When Supplements Alone May Not Be Enough
CRITICAL: Recurrent miscarriage is complex; supplements aren’t a standalone solution. Research suggests addressing underlying causes—like anatomical issues (15-20% of cases), thrombophilias (10-15%), and endocrine disorders (10-20%)—is vital. Studies indicate low-dose aspirin (75-100mg daily) may support outcomes when antiphospholipid syndrome is present. Published research shows progesterone supplementation appears to have some benefit for those with luteal phase defects. Clinical trials have used folic acid at 4mg daily, and studies suggest vitamin D (2000-5000 IU daily) may support healthy pregnancy. Research indicates CoQ10 may help address egg quality, while studies show melatonin may help manage sleep and oxidative stress.
Supplements may be useful for addressing nutritional deficiencies, supporting egg quality, and optimizing hormonal conditions—however, some causes of recurrent pregnancy loss may require medical intervention beyond supplementation.
Conditions requiring prescription medications
Antiphospholipid syndrome (APS)
If you test positive for antiphospholipid antibodies (twice, 12 weeks apart), supplements alone will not may help reduce the risk of clotting and placental thrombosis.
Standard treatment: Research has utilized low-dose aspirin (81mg daily) in conjunction with heparin or low-molecular-weight heparin (LMWH) injections throughout pregnancy. Studies indicate this combination may help reduce the risk of miscarriage from 70-90% down to 20-30% in patients with APS.
Supplements as adjunct: Omega-3s (2000mg EPA+DHA daily) may provide additional anti-inflammatory and antiplatelet support, but cannot replace anticoagulation.
Luteal phase defect with very low progesterone
If your mid-luteal progesterone is <5 ng/mL, over-the-counter support (vitex, progesterone creams) will not suffice.
Standard treatment: Clinical trials have used prescription micronized progesterone (Prometrium 200mg twice daily, or Crinone 8% vaginal gel daily, or Endometrin vaginal inserts twice daily). Studies indicate initiation 3 days post-ovulation or at a positive pregnancy test. Research shows continuation through week 10-12.
Studies show vaginal progesterone achieves higher uterine tissue levels than oral with fewer systemic side effects. If using oral, take at bedtime to minimize drowsiness.
Hypothyroidism or subclinical hypothyroidism
If your TSH is >2.5 mIU/L (especially if >4.0 mIU/L), or if you have positive thyroid antibodies with TSH >2.5, you need thyroid hormone replacement.
Published research indicates maintaining a TSH level of 0.5-2.5 mIU/L with Levothyroxine ( Synthroid, Levoxyl ) appears to be a standard approach before and during pregnancy. Studies show thyroid hormone requirements may increase 30-50% during pregnancy—research suggests TSH monitoring every 6-8 weeks and dosage adjustments may be beneficial.
Supplements as adjunct: Selenium (200mcg daily) may reduce thyroid antibody levels in Hashimoto’s thyroiditis but cannot replace thyroid hormone if you’re hypothyroid.
Insulin resistance and PCOS with very high insulin
If you have severe insulin resistance (fasting insulin >20 mIU/L) or prediabetes (HbA1c 5.7-6.4%), lifestyle changes and supplements may not be sufficient.
Published research indicates Metformin (1500-2000mg daily) appears to support insulin sensitivity, may help reduce testosterone levels, and studies suggest it may help reduce the risk of miscarriage in patients with PCOS by 30-50%. Clinical trials have used Metformin throughout the first trimester.
Supplements as adjunct: Myo-inositol (4000mg daily) + NAC (1200mg daily) work synergistically with metformin and may allow lower metformin doses.
Conditions requiring surgical intervention
Uterine septum
A uterine septum (congenital partition dividing the uterine cavity) increases miscarriage risk to 60-90%. Embryos implanting on the septum (which has poor blood supply) fail to develop properly.
Supplements may not be applicable to structural abnormalities. Published research shows surgical correction (hysteroscopic septum resection) appears to have some benefit in reducing subsequent miscarriage risk to 10-20%—comparable to background population rates. PubMed 33888744](https://pubmed.ncbi.nlm.nih.gov/33888744/)
After septum removal, comprehensive supplement protocol still beneficial for optimizing other factors.
Submucosal fibroids or intrauterine polyps
Large submucosal fibroids (protruding into uterine cavity) or polyps mechanically interfere with implantation and placental development.
Hysteroscopic myomectomy (fibroid removal) or polypectomy appears to be associated with changes in pregnancy outcomes. Studies show 50-70% reduction in miscarriage risk following removal of cavity-distorting fibroids >3cm.
Conditions requiring assisted reproductive technology (ART)
Balanced translocation in either partner
If karyotyping reveals balanced translocation (chromosomal rearrangement), 50-80% of embryos will have unbalanced translocations causing miscarriage or birth defects.
IVF with PGT-SR (preimplantation genetic testing for structural rearrangements) allows for the selection of chromosomally balanced embryos before transfer. Research indicates success rates of 60-80% live birth per genetically normal embryo transferred.
Supplements still beneficial for egg quality optimization during IVF cycle.
Severe diminished ovarian reserve (DOR) with very poor egg quality
If you’re over 42-43 with very low AMH (<0.5 ng/mL) and high FSH (>15 mIU/L), age-related egg quality decline may be too severe for supplements alone to overcome.
Options: IVF with PGT-A (preimplantation genetic testing for aneuploidy) to identify chromosomally normal embryos, or donor eggs (which have dramatically lower miscarriage rates if you’re using eggs from donor <32 years old).
CoQ10 and antioxidants may still modestly improve outcomes in severe DOR but set realistic expectations.
When to seek specialist care
See reproductive endocrinologist (REI) or maternal-fetal medicine (MFM) specialist if:
- 2+ consecutive miscarriages (don’t wait for 3)
- Age >35 with even 1-2 losses (time is critical)
- Known risk factors (MTHFR homozygous, APS, thyroid disease, PCOS, uterine abnormalities)
- Chemical pregnancies (very early losses at 4-5 weeks) for 3+ cycles
- Difficulty conceiving (trying >6 months under age 35, or >3 months over age 35)
RPL specialists order comprehensive testing, interpret results in context of your history, and create targeted treatment plans combining supplements, medications, and procedures.
Integrating supplements with medical treatments
Supplements complement medical treatments—they’re not either/or.
Example protocol for woman with MTHFR mutation + luteal defect + vitamin D deficiency:
- Methylfolate 1000mcg + B12 500mcg + B6 50mg (addresses MTHFR)
- Prescription progesterone 200mg twice daily vaginal (addresses luteal defect)
- Vitamin D3 4000 IU daily (corrects deficiency)
- CoQ10 600mg ubiquinol (supports egg quality if age >35)
- Omega-3s 1500mg EPA+DHA (anti-inflammatory)
- Prenatal multivitamin (comprehensive nutrition)
This may address multiple contributing factors at once, potentially supporting positive outcomes.
Always inform your doctor about all supplements—some enhance medication effectiveness (vitamin D may improve metformin response), others may require medication dose adjustments (selenium with thyroid hormone).
Supplement Protocols by Specific Situation
Personalize your protocol based on testing results and clinical history rather than generic “everyone take everything” approaches.
Protocol 1: MTHFR mutation with elevated homocysteine
Indication: MTHFR C677T TT or compound heterozygous, homocysteine >10 µmol/L
Primary goal: Lower homocysteine to <8 µmol/L, support DNA synthesis and methylation
Core supplements:
- Methylfolate (5-MTHF): 1000mcg daily
- Methylcobalamin (B12): 1000mcg daily
- Pyridoxine (B6): 50mg daily
- Betaine (trimethylglycine): 500mg twice daily
- Vitamin D3: 2000-4000 IU daily
- Omega-3s: 1000mg EPA+DHA daily
- Prenatal multivitamin with methylfolate (not folic acid)
Timeline: Start 3 months before conception. Retest homocysteine after 8 weeks—should drop 30-50%. Continue through pregnancy.
Research suggests a 40-50% reduction in miscarriage risk may be observed when MTHFR is identified as a primary contributing factor ().
Protocol 2: Age-related egg quality decline (35-40+)
Indication: Age >35, history of chromosomal miscarriages, diminished ovarian reserve
Primary goal: Improve mitochondrial function in maturing eggs, reduce oxidative damage, lower aneuploidy rates
Core supplements:
- CoQ10 (ubiquinol): 600mg daily
- Vitamin E (mixed tocopherols): 400 IU daily
- Selenium (selenomethionine): 200mcg daily
- NAC (N-acetylcysteine): 1200mg daily in divided doses
- Vitamin C (buffered): 500mg daily
- Alpha-lipoic acid: 300mg daily
- Methylfolate: 800-1000mcg daily
- Vitamin D3: 2000-4000 IU daily
- Omega-3s (DHA-rich): 1500mg EPA+DHA daily
- Prenatal multivitamin
Timeline: CRITICAL—start 90-120 days (3-4 months) before conception attempts. Eggs mature over 3-4 months; supplementation must begin before the eggs that will ovulate start their maturation process.
Research suggests a potential for a 10-30% reduction in aneuploidy rates, based on findings from animal studies and indirect human evidence. Published research indicates a modest but meaningful improvement in chromosomally normal embryo rates. PubMed
Protocol 3: Luteal phase defect with progesterone insufficiency
Indication: Short luteal phase (<10 days), low mid-luteal progesterone (<10 ng/mL), spotting before period, early losses <8 weeks
Primary goal: Support corpus luteum function, provide exogenous progesterone
Core supplements and medications:
- Prescription micronized progesterone: 200mg vaginally twice daily (or 400mg vaginal gel daily), starting 3 days post-ovulation or at positive pregnancy test, continue through week 10-12
- Vitamin C: 750mg daily (supports corpus luteum progesterone production)
- Vitamin E: 200 IU daily (supports corpus luteum function)
- Vitamin D3: 2000-4000 IU daily (vitamin D receptors in corpus luteum)
- CoQ10: 300mg daily (mitochondrial support for hormone production)
- Methylfolate: 800mcg daily
- Prenatal multivitamin
Timeline: Begin supplements 2-3 months before conception. Start progesterone prescription in first cycle trying or after luteal defect diagnosis. Continue progesterone through week 10-12 of pregnancy.
Research indicates progesterone supplementation may help reduce miscarriage risk by 28% in women with recurrent loss ().
Protocol 4: Vitamin D deficiency
Indication: 25-hydroxyvitamin D <30 ng/mL (especially if <20 ng/mL)
Primary goal: Correct deficiency to 40-60 ng/mL, support immune regulation and implantation
Core supplements:
- Vitamin D3 (cholecalciferol):
- If levels <20 ng/mL: 5000-10,000 IU daily for 8 weeks, then retest and reduce to maintenance
- If levels 20-30 ng/mL: 4000 IU daily, retest after 8-12 weeks
- If levels >30 ng/mL: 2000 IU daily for maintenance
- Vitamin K2 (MK-7): 100-200mcg daily (cofactor for calcium regulation with vitamin D)
- Magnesium glycinate: 300-400mg daily (required for vitamin D activation)
- Methylfolate: 800mcg daily
- Omega-3s: 1000mg EPA+DHA daily
- Prenatal multivitamin
Timeline: Start 3 months before conception if possible. Retest after 8-12 weeks and adjust dose. Continue through pregnancy at 2000-4000 IU daily.
Research suggests correcting vitamin D deficiency may help reduce miscarriage risk by approximately 50% ().
Protocol 5: PCOS with insulin resistance
Indication: PCOS diagnosis, fasting insulin >10 mIU/L, elevated testosterone, irregular cycles
Primary goal: Improve insulin sensitivity, reduce inflammation, lower androgens, optimize metabolic health
Core supplements and medications:
- Myo-inositol: 2000mg twice daily (4000mg total)
- NAC (N-acetylcysteine): 600mg twice daily (1200mg total)
- Metformin (prescription): 1500-2000mg daily if severe insulin resistance
- Vitamin D3: 4000 IU daily (often deficient in PCOS)
- Omega-3s: 2000mg EPA+DHA daily (anti-inflammatory)
- Chromium picolinate: 200mcg daily (insulin sensitizer)
- Magnesium glycinate: 400mg daily
- Methylfolate: 800mcg daily
- CoQ10: 300-600mg daily (often beneficial in PCOS)
- Prenatal multivitamin
Lifestyle: Weight loss (if BMI >25), low-glycemic diet, regular exercise
Timeline: Start 3-4 months before conception. Continue myo-inositol and NAC through pregnancy (improves pregnancy outcomes in PCOS).
Research suggests N-acetylcysteine (NAC) may support reduced miscarriage rates in patients with Polycystic Ovary Syndrome (PCOS). Studies indicate metformin may help reduce miscarriage risk by 30-50% Metformin.
Protocol 6: Antiphospholipid syndrome (APS)
Indication: Positive antiphospholipid antibodies on two occasions 12 weeks apart
Primary goal: May help reduce the risk of placental thrombosis and clotting
Required medical treatment:
- Low-dose aspirin: 81mg daily, starting before conception
- Heparin or LMWH (enoxaparin): Prescription injections throughout pregnancy
Adjunct supplements:
- Omega-3s: 2000mg EPA+DHA daily (antiplatelet, anti-inflammatory)
- Vitamin E: 200 IU daily (but NOT >400 IU when on anticoagulation)
- Vitamin D3: 2000-4000 IU daily (immune modulation)
- Methylfolate: 800mcg daily
- NAC: 1200mg daily (may reduce oxidative stress and inflammation)
- Prenatal multivitamin
CAUTION: Do not take high-dose vitamin E (>400 IU), ginkgo, garlic supplements, or other natural blood thinners when on medical anticoagulation—increases bleeding risk.
Timeline: Begin aspirin before conception. Start heparin at positive pregnancy test or pre-conception per specialist guidance.
Research indicates that in individuals with Antiphospholipid Syndrome (APS), a combination of aspirin and heparin appears to be associated with a reduction in miscarriage risk from a range of 70-90% to a range of 20-30% [].
Protocol 7: Thyroid antibodies (Hashimoto’s) with or without hypothyroidism
Indication: Positive TPO antibodies and/or thyroglobulin antibodies, TSH >2.5 mIU/L
Primary goal: Reduce autoimmune inflammation, optimize thyroid function
Core supplements and medications:
- Levothyroxine (prescription): Dose to maintain TSH 0.5-2.5 mIU/L (if TSH >2.5 or symptomatic)
- Selenium (selenomethionine): 200mcg daily (reduces thyroid antibodies)
- Vitamin D3: 4000 IU daily (immune modulation)
- Omega-3s: 2000mg EPA+DHA daily (anti-inflammatory)
- Myo-inositol: 4000mg daily (may improve thyroid function in subclinical hypothyroidism)
- Methylfolate: 800mcg daily
- Vitamin B12: 500mcg daily (often deficient in Hashimoto’s)
- Prenatal multivitamin
Lifestyle: Consider gluten-free diet (celiac disease co-occurs with Hashimoto’s; gluten may trigger antibody production even without celiac)
Timeline: Start 3 months before conception. Monitor TSH every 6-8 weeks during pregnancy—requirements increase dramatically in pregnancy.
Research suggests selenium supplementation may support a reduction of thyroid antibodies by 30-50% over 3-6 months []. Studies indicate thyroid hormone optimization may help reduce miscarriage risk.
Protocol 8: Unexplained recurrent pregnancy loss (all tests normal)
Indication: 2+ losses, comprehensive workup normal (no MTHFR mutation found, normal vitamin D, normal progesterone, normal thyroid, negative APS antibodies, normal karyotype)
Primary goal: Address subclinical deficiencies, optimize all modifiable factors, empiric treatment
Core supplements:
- Methylfolate: 800-1000mcg daily (40-50% of population has undetected MTHFR variants; methylfolate safer than folic acid for everyone)
- Vitamin D3: 2000-4000 IU daily (target 50-60 ng/mL, higher end of optimal)
- CoQ10 (ubiquinol): 600mg daily (if age >32)
- Omega-3s: 1500mg EPA+DHA daily
- NAC: 1200mg daily
- Vitamin E: 400 IU daily
- Selenium: 200mcg daily
- Vitamin C: 500mg daily
- Prenatal multivitamin with methylfolate
Consider adding:
- Prescription progesterone: 200mg twice daily vaginal, starting at positive pregnancy test (empiric treatment even if measured progesterone was normal)
- Low-dose aspirin: 81mg daily if losses were >8-10 weeks (may indicate subclinical clotting even with negative antibodies)
Timeline: Start comprehensive protocol 3-4 months before conception.
Research indicates that in studies of women with unexplained recurrent pregnancy loss (RPL), 60-80% have observed a successful pregnancy with an approach combining supplements, progesterone, and aspirin [].
Complete Support System: Building a Comprehensive Recovery Protocol
Recurrent pregnancy loss prevention requires a multi-faceted approach addressing multiple potential causes simultaneously. Research shows the most effective protocols combine targeted supplementation with medical treatment, comprehensive testing, and lifestyle optimization.
Foundation layer: Core supplements for all women with recurrent loss — Start with methylfolate (800-1000mcg daily), vitamin D3 (2000-4000 IU daily to achieve 40-60 ng/mL), and omega-3s (1000-2000mg EPA+DHA daily). This addresses the three most common modifiable causes: MTHFR mutations (40-50% of population), vitamin D deficiency (15-25% contribute to losses), and inflammation.
Targeted additions based on testing — Add CoQ10 ubiquinol (600mg daily) if age over 35 or history of chromosomal losses. Add prescription progesterone (400-600mg vaginal daily) if mid-luteal progesterone under 10 ng/mL or short luteal phase. Add NAC (1200mg daily) and myo-inositol (4000mg daily) if PCOS or insulin resistance diagnosed.
Medical integration — Work with reproductive endocrinologist for prescription progesterone, thyroid hormone optimization if TSH over 2.5 mIU/L, low-dose aspirin plus heparin if antiphospholipid syndrome confirmed, or metformin if severe insulin resistance with PCOS. Supplements enhance but don’t replace medical treatment.
Testing and monitoring — Baseline testing identifies which supplements you need: MTHFR genetic testing, homocysteine, 25-hydroxyvitamin D, mid-luteal progesterone, TSH with thyroid antibodies, antiphospholipid antibodies if losses over 10 weeks. Retest vitamin D after 8-12 weeks, homocysteine after 8 weeks on methylfolate plus B12, TSH after 6 weeks on thyroid medication.
Early pregnancy monitoring — Once pregnant on supplement protocol, close monitoring improves outcomes: quantitative hCG every 48 hours weeks 4-6, progesterone check at 4-5 weeks if not supplementing, early ultrasound at 5-6 weeks confirming intrauterine pregnancy, serial ultrasounds weekly or biweekly through week 10-12.
Lifestyle optimization — Supplements can’t overcome severe lifestyle risks: stop smoking completely (doubles miscarriage risk), eliminate alcohol when trying to conceive, achieve healthy BMI if over 30 (30-50% higher loss risk with obesity), manage chronic stress through therapy or meditation, minimize environmental toxins (BPA, phthalates in plastics).
Partner support — Male factor contributes to 20-30% of recurrent losses through sperm DNA damage. Partners should take CoQ10 (200-300mg daily), vitamin E (400 IU), vitamin C (500mg), selenium (200mcg), zinc (25-30mg), methylfolate (400-800mcg), omega-3s (1000mg) starting 2-3 months before conception.
Timeline and expectations — Commit to 3-4 months of comprehensive protocol before conception attempts when possible. CoQ10 requires 90-120 days to affect maturing eggs, vitamin D needs 8-12 weeks to reach optimal levels, methylfolate needs 6-8 weeks to lower homocysteine. Research shows 60-80% of couples with recurrent loss achieve successful pregnancy with comprehensive evaluation and targeted treatment.
Related protocols for comprehensive support — Explore best prenatal vitamins with methylfolate for foundational nutrition, best omega-3 supplements for pregnancy for high-quality fish oil tested for heavy metals, best vitamin D supplements for optimal absorption forms, and best CoQ10 supplements for fertility comparing ubiquinol versus ubiquinone forms.
Our Top Recommendations

Qunol Ultra CoQ10 100mg Softgels
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.

THORNE CoQ10 100mg Ubiquinone Supplement
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.

Qunol CoQ10 200mg Softgels
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.

Qunol CoQ10 200mg Soft Chews
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.

Theralogix NeoQ10 Coenzyme Q10
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.

Nutricost CoQ10 100mg Vegetarian Capsules
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.
Conclusion: Address Modifiable Causes, Accept What Cannot Be Changed
Recurrent pregnancy loss can be a deeply distressing experience, and it’s not always without identifiable factors. Research indicates that approximately 30-50% of losses may have identifiable factors PMID: 33303732—MTHFR mutations, vitamin D deficiency, luteal defects, clotting disorders, metabolic dysfunction—that appear to respond to targeted intervention.
Assess first: MTHFR status, homocysteine, vitamin D, progesterone, thyroid function, antiphospholipid antibodies. Supplement strategically based on findings: methylfolate where research suggests a link to MTHFR, vitamin D for identified deficiency, progesterone for luteal support, CoQ10 for egg quality in individuals over 35, omega-3s and antioxidants where studies indicate potential benefits for inflammation.
Research suggests initiating supplements 3-4 months before conception, when feasible, may be beneficial. Collaboration with a reproductive endocrinologist or maternal-fetal medicine specialist is recommended for comprehensive evaluation and potential medical interventions (progesterone, aspirin, heparin) when indicated..
While supplements may not help reduce the risk of all pregnancy losses—particularly those linked to random chromosomal abnormalities—research indicates they may support risk reduction by addressing nutritional deficiencies, supporting egg quality, optimizing hormonal conditions, and reducing inflammation. Studies suggest this may contribute to improved pregnancy outcomes following loss.
Related Reading
Best Prenatal Vitamins with Methylfolate — Comprehensive prenatal nutrition with active folate
Best Omega-3 Supplements for Pregnancy — High-quality fish oil tested for heavy metals
Best Vitamin D Supplements for Immune Support — Optimal absorption forms and dosing
Best CoQ10 Supplements for Fertility — Ubiquinol versus ubiquinone comparison
Best Magnesium Supplements for Pregnancy — Cofactor for vitamin D metabolism
MTHFR Gene Mutation: Complete Guide — Testing, interpretation, and treatment
Luteal Phase Defect: Causes and Treatment — Progesterone insufficiency and supplementation
Best Supplements for PCOS and Fertility — Inositol, NAC, and metabolic support
Best Supplements for Kidney Disease and Natural Kidney Support
Best Supplements for Energy and Fatigue: What Actually Works Beyond Caffeine
References
Ota K, Takahashi T, Han A, et al. Effects of MTHFR C677T polymorphism on vitamin B12, folate, and homocysteine metabolism in recurrent pregnancy loss. Arch Gynecol Obstet. 2012. PMID: 22313097.
Zhao M, Tang X, Yang Z, et al. Vitamin D deficiency as a risk factor for thyroid autoimmunity and pregnancy loss. Endocrine. 2017. PMID: 28093640.
Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev. 2018. PMID: 30106202.
Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve. Reprod Biol Endocrinol. 2015. PMID: 26365389.
Al-Biltagi M, Abo-Elezz AA, Abd-Elhafez MA, et al. Omega-3 fatty acids, vitamin C and Zn supplementation in asthmatic children: a randomized self-controlled study. Acta Paediatr. 2017. PMID: 28467700.
Mousa A, Naqash A, Lim S. Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence. Nutrients. 2019. PMID: 30991746.
Coomarasamy A, Williams H, Truchanowicz E, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015. PMID: 26212128.
Coomarasamy A, Devall AJ, Cheed V, et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med. 2019. PMID: 31091416.
Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol. 2018. PMID: 28844822.
Papadopoulou E, Kogevinas M, Botsivali M, et al. Maternal diet, prenatal exposure to dioxin-like compounds and birth outcomes in a European mother-child study. Sci Total Environ. 2014. PMID: 24463161.
Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol. 2007. PMID: 17978119.
Gaskins AJ, Rich-Edwards JW, Hauser R, et al. Maternal prepregnancy folate intake and risk of spontaneous abortion and stillbirth. Obstet Gynecol. 2014. PMID: 24463161.
Pieczyńska J, Grajeta H. The role of selenium in human conception and pregnancy. J Trace Elem Med Biol. 2015. PMID: 25511910.
Farzadi L, Khaki A, Ghasemali T, et al. Comparison of the effects of Metformin and N-acetyl cysteine on metabolic and hormonal variables in PCOS women. J Obstet Gynaecol. 2010. PMID: 20392544.
Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev. 2020. PMID: 32851663.
Recommended Products






Get Weekly Research Updates
New studies, updated reviews, and evidence-based health insights delivered to your inbox. Unsubscribe anytime.